Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Tamburrino

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Trends in Neurosciences|March 14, 2016
Aged and Diseased Neurons Get Lost in TransportAnna Tamburrino, Mickael Decressac
Current Opinion in Pharmacology|July 17, 2013
Rationale and clinical use of multitargeting anticancer agentsDavide Melisi, Geny Piro, Anna Tamburrino, et al.
Frontiers in Pharmacology|May 4, 2013
Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapyAnna Tamburrino, Geny Piro, Carmine Carbone, et al.
Biomedicines|May 27, 2017
Toll-Like Receptor 9 Agonists for Cancer TherapyDavide Melisi, Melissa Frizziero, Anna Tamburrino, et al.
Experimental and Molecular Pathology|May 21, 2013
Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinomaJena Hudson, Eric Duncavage, Anna Tamburrino, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2008
Functional characterization of the novel T599I-VKSRdel BRAF mutation in a follicular variant papillary thyroid carcinomaValentina De Falco, Riccardo Giannini, Anna Tamburrino, et al.
Cancer Research|January 25, 2012
CD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cellsValentina De Falco, Anna Tamburrino, Simona Ventre, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 2, 2016
Targeting α-synuclein: Therapeutic optionsBenjamin Dehay, Mickael Decressac, Mathieu Bourdenx, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2009
Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cellsPaolo Salerno, Valentina De Falco, Anna Tamburrino, et al.
Endocrine Reviews|February 16, 2017
Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma CellsPaolo Salerno, Valentina De Falco, Anna Tamburrino, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Trends in Neurosciences|March 14, 2016
Aged and Diseased Neurons Get Lost in TransportAnna Tamburrino, Mickael Decressac
Current Opinion in Pharmacology|July 17, 2013
Rationale and clinical use of multitargeting anticancer agentsDavide Melisi, Geny Piro, Anna Tamburrino, et al.
Frontiers in Pharmacology|May 4, 2013
Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapyAnna Tamburrino, Geny Piro, Carmine Carbone, et al.
Biomedicines|May 27, 2017
Toll-Like Receptor 9 Agonists for Cancer TherapyDavide Melisi, Melissa Frizziero, Anna Tamburrino, et al.
Experimental and Molecular Pathology|May 21, 2013
Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinomaJena Hudson, Eric Duncavage, Anna Tamburrino, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2008
Functional characterization of the novel T599I-VKSRdel BRAF mutation in a follicular variant papillary thyroid carcinomaValentina De Falco, Riccardo Giannini, Anna Tamburrino, et al.
Cancer Research|January 25, 2012
CD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cellsValentina De Falco, Anna Tamburrino, Simona Ventre, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 2, 2016
Targeting α-synuclein: Therapeutic optionsBenjamin Dehay, Mickael Decressac, Mathieu Bourdenx, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2009
Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cellsPaolo Salerno, Valentina De Falco, Anna Tamburrino, et al.
Endocrine Reviews|February 16, 2017
Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma CellsPaolo Salerno, Valentina De Falco, Anna Tamburrino, et al.
Pageof 2